210 related articles for article (PubMed ID: 25933700)
1. Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy-a survey of health care providers and patients.
Jacobs C; Hutton B; Mazzarello S; Smith S; Joy A; Amir E; Ibrahim MF; Gregario N; Daigle K; Eggert L; Clemons M
Support Care Cancer; 2015 Nov; 23(11):3269-75. PubMed ID: 25933700
[TBL] [Abstract][Full Text] [Related]
2. A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy.
Hsu T; Fergusson D; Stober C; Daigle K; Moledina N; Vandermeer L; Pond G; Hilton J; Hutton B; Clemons M;
Support Care Cancer; 2021 Jun; 29(6):3113-3120. PubMed ID: 33057999
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly?
Schwartz JR
J Oncol Pharm Pract; 2012 Jun; 18(2):250-6. PubMed ID: 21807762
[TBL] [Abstract][Full Text] [Related]
4. Safe dose reduction of steroid pre-medication for docetaxel in head and neck neoplasm treatment.
Chen NX; Zhao FF; Yan F; Zhang XX
Acta Otolaryngol; 2016; 136(2):177-80. PubMed ID: 26472564
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effects and adverse drug reactions of low-dose dexamethasone premedication with weekly docetaxel.
Kang RY; Yoo KS; Han HJ; Lee JY; Lee SH; Kim DW; Lee YJ
Support Care Cancer; 2017 Feb; 25(2):429-437. PubMed ID: 27687722
[TBL] [Abstract][Full Text] [Related]
6. Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy.
Parinyanitikul N; Tanpipattanakul W; Poovorawan N; Rattananupong T; Laoitthi P; Sithidetphaiboon P; Thanasanvimon S; Sriuranpong V
Support Care Cancer; 2018 Jul; 26(7):2471-2477. PubMed ID: 29435713
[TBL] [Abstract][Full Text] [Related]
7. Single premedication dose of dexamethasone 20 mg IV before docetaxel administration.
Chouhan JD; Herrington JD
J Oncol Pharm Pract; 2011 Sep; 17(3):155-9. PubMed ID: 20447949
[TBL] [Abstract][Full Text] [Related]
8. Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution survey.
Kawaguchi K; Ishiguro H; Morita S; Nakamura S; Ohno S; Masuda N; Iwata H; Aogi K; Kuroi K; Toi M;
Breast Cancer Res Treat; 2011 Nov; 130(2):627-34. PubMed ID: 21698408
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
[TBL] [Abstract][Full Text] [Related]
10. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
Hudis CA; Seidman AD; Crown JP; Balmaceda C; Freilich R; Gilewski TA; Hakes TB; Currie V; Lebwohl DE; Baselga J; Raptis G; Gollub M; Robles M; Bruno R; Norton L
J Clin Oncol; 1996 Jan; 14(1):58-65. PubMed ID: 8558221
[TBL] [Abstract][Full Text] [Related]
11. Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions.
Lansinger OM; Biedermann S; He Z; Colevas AD
J Clin Oncol; 2021 Nov; 39(32):3583-3590. PubMed ID: 34357780
[TBL] [Abstract][Full Text] [Related]
12. Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
Berger MJ; Vargo C; Vincent M; Shaver K; Phillips G; Layman R; Macrae E; Mrozek E; Ramaswamy B; Wesolowski R; Shapiro CL; Lustberg MB
Support Care Cancer; 2015 Jul; 23(7):2019-24. PubMed ID: 25519756
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.
Trudeau ME; Eisenhauer EA; Higgins BP; Letendre F; Lofters WS; Norris BD; Vandenberg TA; Delorme F; Muldal AM
J Clin Oncol; 1996 Feb; 14(2):422-8. PubMed ID: 8636752
[TBL] [Abstract][Full Text] [Related]
14. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
15. Self-Administered Premedication: Improving Taxane Chemotherapy Treatment
.
Roper K; Siefert ML; Fuller F; Lucier D; Berry DL
Clin J Oncol Nurs; 2017 Apr; 21(2):234-239. PubMed ID: 28315538
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of dexamethasone premedication regimens with docetaxel chemotherapy in early HER-2 positive breast cancer: A safety net hospital experience.
Hager A; Kondle S; Agarwal A; Chintapenta M; Horadam R; Sadeghi N; Syed S
J Oncol Pharm Pract; 2024 Feb; ():10781552241232692. PubMed ID: 38425269
[TBL] [Abstract][Full Text] [Related]
17. Risks and benefits of taxanes in breast and ovarian cancer.
Michaud LB; Valero V; Hortobagyi G
Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of prior administration of cyclophosphamide in TC combination treatment.
Abe H; Kawai Y; Mori T; Cho H; Kubota Y; Umeda T; Tani T
Breast Cancer; 2014 Mar; 21(2):202-7. PubMed ID: 22696251
[TBL] [Abstract][Full Text] [Related]
19. Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study.
Llombart-Cussac A; Ramos M; Dalmau E; García-Saenz JA; González-Farré X; Murillo L; Calvo L; Morales S; Carañana V; González A; Fernández-Morales LA; Moreno F; Casas MI; Angulo Mdel M; Cámara MC; Garcia-Mace AI; Carrasco E; Jara-Sánchez C
Eur J Cancer; 2016 May; 58():122-9. PubMed ID: 26994459
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
